Bull World Health Organ. 1991;69(5):541-8.
The results are described of a meta-analysis of seven randomized trials that compared the clinical effects of the standard solution of WHO oral rehydration salts (ORS), containing 20 milligrams of glucose, and experimental ORS solutions, containing glycine, on 643 children with acute noncholera diarrhoea. The availability of data on individual patients in each trial permitted the scope of the meta-analysis to be enhanced because the data could be pooled after adjusting for differences in baseline patient characteristics; also, the statistical strategy in terms of data quality, post-randomization exclusion of patients, and regression modelling could be standardized for all trials. The results of the analysis showed that neither stool output nor duration of diarrhoea was reduced by the experimental formulations. Only for weight gain was there a statistically significant difference between the treatment groups (those given the WHO-ORS solution gained less weight). This probably reflects transient excess fluid retention within the gut lumen or tissues of the patients who received the glycine-containing solutions. ORS formulations that contain glycine are therefore not clinically superior to the WHO-ORS solution.
对七项随机试验进行了荟萃分析,比较了含20毫克葡萄糖的世界卫生组织口服补液盐(ORS)标准溶液与含甘氨酸的实验性ORS溶液对643例急性非霍乱性腹泻儿童的临床效果。由于各试验中可获取个体患者的数据,因此可在调整基线患者特征差异后合并数据,从而扩大了荟萃分析的范围;此外,所有试验在数据质量、随机分组后患者排除情况及回归模型方面的统计策略均可实现标准化。分析结果显示,实验性配方并未减少粪便排出量或腹泻持续时间。仅在体重增加方面,治疗组之间存在统计学显著差异(接受世界卫生组织ORS溶液的患者体重增加较少)。这可能反映了接受含甘氨酸溶液的患者肠道腔或组织内短暂的液体潴留过多。因此,含甘氨酸的ORS配方在临床上并不优于世界卫生组织的ORS溶液。